|
|
||||||||
1Department of Internal Medicine, Section of Endocrinology and Metabolism, 2Department of Cellular and Molecular Physiology, and the 3Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut; and 4Ste-Justine Hospital and 5Centre Hospitalier de lUniversité de Montreal, University of Montreal, Montreal, Canada
Submitted 14 June 2004 ; accepted in final form 7 February 2005
Insulin resistance in skeletal muscle and heart plays a major role in the development of type 2 diabetes and diabetic heart failure and may be causally associated with altered lipid metabolism. Hormone-sensitive lipase (HSL) is a rate-determining enzyme in the hydrolysis of triglyceride in adipocytes, and HSL-deficient mice have reduced circulating fatty acids and are resistant to diet-induced obesity. To determine the metabolic role of HSL, we examined the changes in tissue-specific insulin action and glucose metabolism in vivo during hyperinsulinemic euglycemic clamps after 3 wk of high-fat or normal chow diet in awake, HSL-deficient (HSL-KO) mice. On normal diet, HSL-KO mice showed a twofold increase in hepatic insulin action but a 40% decrease in insulin-stimulated cardiac glucose uptake compared with wild-type littermates. High-fat feeding caused a similar increase in whole body fat mass in both groups of mice. Insulin-stimulated glucose uptake was reduced by 5080% in skeletal muscle and heart of wild-type mice after high-fat feeding. In contrast, HSL-KO mice were protected from diet-induced insulin resistance in skeletal muscle and heart, and these effects were associated with reduced intramuscular triglyceride and fatty acyl-CoA levels in the fat-fed HSL-KO mice. Overall, these findings demonstrate the important role of HSL on skeletal muscle, heart, and liver glucose metabolism.
glucose metabolism; lipid metabolism; high-fat feeding; insulin action; triglyceride
This article has been cited by other articles:
![]() |
R. Zechner, P. C. Kienesberger, G. Haemmerle, R. Zimmermann, and A. Lass Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores J. Lipid Res., January 1, 2009; 50(1): 3 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fernandez, M. Lindholm, M. Krogh, S. Lucas, S. Larsson, P. Osmark, K. Berger, J. Boren, B. Fielding, K. Frayn, et al. Disturbed cholesterol homeostasis in hormone-sensitive lipase-null mice Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E820 - E831. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ueno, J. Suzuki, Y. Zenimaru, S. Takahashi, T. Koizumi, S. Noriki, O. Yamaguchi, K. Otsu, W.-J. Shen, F. B. Kraemer, et al. Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1109 - E1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fex, S. Lucas, M. S. Winzell, B. Ahren, C. Holm, and H. Mulder {beta}-Cell Lipases and Insulin Secretion Diabetes, December 1, 2006; 55(Supplement_2): S24 - S31. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Park, Y.-R. Cho, H.-J. Kim, E.-G. Hong, T. Higashimori, S. J. Lee, I. J. Goldberg, G. I. Shulman, S. M. Najjar, and J. K. Kim Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1 Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E517 - E524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Hertzel, L. A. Smith, A. H. Berg, G. W. Cline, G. I. Shulman, P. E. Scherer, and D. A. Bernlohr Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E814 - E823. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Pederson, J. M. Schroeder, G. E. Parker, M. W. Smith, A. A. DePaoli-Roach, and P. J. Roach Glucose Metabolism in Mice Lacking Muscle Glycogen Synthase Diabetes, December 1, 2005; 54(12): 3466 - 3473. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |